Evidence map›Paper›PMID 28692730›Full record

ArticleJAMA neurology2017

Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.

Adriano Chiò, Gabriele Mora, Cristina Moglia, Umberto Manera, Antonio Canosa, Stefania Cammarosano, Antonio Ilardi, Davide Bertuzzo, Enrica Bersano, Paolo Cugnasco and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Brain metabolic connectivity in ALS due to C9ORF72 hexanucleotide expansion: a [European journal of nuclear medicine and molecular imaging · 2026
    Article
  12. Article
  13. Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease.Annals of clinical and translational neurology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. ALS global day 2025: research and clinical advances.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Adriano ChiòALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Gabriele MoraALS Center, "Salvatore Maugeri" Clinical-Scientific Institutes, Istituto di Ricovero e Cura a Carattere Scientifico, Milano, Italy.
Cristina MogliaALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Umberto ManeraALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Antonio CanosaALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Stefania CammarosanoALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Antonio IlardiALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Davide BertuzzoALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Enrica BersanoALS Center, the Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
Paolo CugnascoALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Maurizio GrassanoALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Fabrizio PisanoDepartment of Neurological Rehabilitation, "Salvatore Maugeri" Clinical-Scientific Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Veruno, Italy.
Letizia MazziniALS Center, the Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
Andrea CalvoALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Torino, Torino, Italy.
Piemonte and Valle d’Aosta Register for ALS (PARALS)
University of Turin · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITAzienda Ospedaliero Universitaria Maggiore della Carita · ITNeuroscience Institute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: This study reports the long-term epidemiologic trends of amyotrophic lateral sclerosis (ALS) based on a prospective register. Objective: To examine the 20-year epidemiologic trends of ALS in the Piemonte and Valle d'Aosta regions of Italy. Design, Setting, and Participants: The Piemonte and Valle d'Aosta Register for ALS (PARALS) is an epidemiologic prospective register that covers 2 Italian regions (population of 4 476 931 inhabitants according to the 2011 census) from January 1, 1995, through December 31, 2014. Case ascertainment is based on multiple sources (neurologic departments, hospital discharge archives, and mortality records). Incidence rates are age and sex standardized for the Italian population of the 2011 census. Age-period-cohort (APC) analysis was performed using a Poisson regression model. Main Outcomes and Measures: The primary study outcomes were long-term incidence and prevalence rates of ALS using a prospective design and their determinants. Results: During the study period, a total of 2702 patients (mean [SD] age at onset, 65.7 [11.1] years; 1246 [46.1%] female and 1456 [53.9%] male) received a diagnosis of ALS between 1995 and 2014, corresponding to a crude annual incidence rate of 3.03 per 100 000 population (95% CI, 2.85-3.23) and an adjusted incidence rate of 2.78 per 100 000 population (95% CI, 2.57-2.96). The age-adjusted incidence rate increased in the 2 decades of the study (1995-2004: 2.66; 95% CI, 2.50-2.83; 2005-2014: 2.89; 95% CI, 2.71-3.07; P = .04), mostly in women. The adjusted rate ratio of men to women decreased from 1.27:1 (1995-2004) to 1.17:1 (2005-2014). The analysis of deviance for the APC regression models indicated that the drift variable is relevant in explaining the variation of ALS incidence rates over time in the overall population (change in deviance, 4.6553; P = .03) and in women (change in deviance, 3.8821; P = .05) but not in men (change in deviance, 0.77215; P = .38). A total of 479 patients with ALS were alive and had not undergone tracheostomy at the prevalence day (December 31, 2014), corresponding to a crude prevalence rate of 10.54 per 100 000 population (95% CI, 9.64-11.52). Conclusions and Relevance: During the 1995 to 2014 period, the crude and adjusted incidences of ALS increased in Piemonte and Valle d'Aosta, mostly in women. The APC model revealed that the increase of ALS incidence is attributable to a birth cohort effect in women, with a peak in the 1930 cohort. The different increase of ALS incidence in men and women points to an effect of exogenous factors with a differential effect on the 2 sexes, acting on a genetic background.

Indexed as

AgedAge of OnsetAmyotrophic Lateral SclerosisFemaleHumansIncidenceItalyMaleMiddle AgedPrevalenceProspective StudiesRegistriesSex Factors

Identifiers

PMID28692730
PMCPMC5710181
OpenAlexW2735544048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.